LifeTech Scientific Corporation provided earnings guidance for the six months ended June 30, 2021. For the period, the company expected to record no less than RMB 200.0 million in profit attributable to owners of the Company, representing an increase ranging from 100% to 110% for the six months as compared to the corresponding period in 2020, and an increase ranging from 110% to 120% as compared to the corresponding period in 2019.